Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 1
1989 6
1991 1
1992 1
1994 2
1995 4
1996 11
1997 4
1998 6
1999 4
2000 8
2001 5
2002 8
2003 4
2004 6
2005 4
2006 6
2007 4
2008 5
2009 8
2010 8
2011 12
2012 5
2013 13
2014 18
2015 16
2016 14
2017 19
2018 12
2019 11
2020 20
2021 16
2022 20
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

258 results

Results by year

Filters applied: . Clear all
Page 1
Cancer-Related Fatigue, Version 2.2015.
Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C; National comprehensive cancer network. Berger AM, et al. Among authors: breitbart ws. J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39. doi: 10.6004/jnccn.2015.0122. J Natl Compr Canc Netw. 2015. PMID: 26285247 Free PMC article.
Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual funct
Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness o
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
Riba MB, Donovan KA, Andersen B, Braun I, Breitbart WS, Brewer BW, Buchmann LO, Clark MM, Collins M, Corbett C, Fleishman S, Garcia S, Greenberg DB, Handzo RGF, Hoofring L, Huang CH, Lally R, Martin S, McGuffey L, Mitchell W, Morrison LJ, Pailler M, Palesh O, Parnes F, Pazar JP, Ralston L, Salman J, Shannon-Dudley MM, Valentine AD, McMillian NR, Darlow SD. Riba MB, et al. Among authors: breitbart ws. J Natl Compr Canc Netw. 2019 Oct 1;17(10):1229-1249. doi: 10.6004/jnccn.2019.0048. J Natl Compr Canc Netw. 2019. PMID: 31590149 Free PMC article.
Distress is defined in the NCCN Guidelines for Distress Management as a multifactorial, unpleasant experience of a psychologic (ie, cognitive, behavioral, emotional), social, spiritual, and/or physical nature that may interfere with the ability to cope effectively with cancer
Distress is defined in the NCCN Guidelines for Distress Management as a multifactorial, unpleasant experience of a psychologic (ie, cognitiv …
Meanwhile.
Breitbart W. Breitbart W. Palliat Support Care. 2023 Feb;21(1):1-2. doi: 10.1017/S1478951523000093. Palliat Support Care. 2023. PMID: 36814146 Free PMC article. No abstract available.
Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial.
Hui D, De La Rosa A, Wilson A, Nguyen T, Wu J, Delgado-Guay M, Azhar A, Arthur J, Epner D, Haider A, De La Cruz M, Heung Y, Tanco K, Dalal S, Reddy A, Williams J, Amin S, Armstrong TS, Breitbart W, Bruera E. Hui D, et al. Among authors: breitbart w. Lancet Oncol. 2020 Jul;21(7):989-998. doi: 10.1016/S1470-2045(20)30307-7. Epub 2020 May 29. Lancet Oncol. 2020. PMID: 32479786 Free PMC article. Clinical Trial.
We assessed the effect of three neuroleptic strategies on refractory agitation in patients with cancer with terminal delirium. METHODS: In this single-centre, double-blind, parallel-group, randomised trial, patients with advanced cancer, aged at least 18 years, admi …
We assessed the effect of three neuroleptic strategies on refractory agitation in patients with cancer with terminal delirium. METHOD …
Existential isolation.
Breitbart W. Breitbart W. Palliat Support Care. 2017 Aug;15(4):403-404. doi: 10.1017/S1478951517000621. Epub 2017 Jun 23. Palliat Support Care. 2017. PMID: 28641587 Free PMC article. No abstract available.
Forgiveness.
Breitbart W. Breitbart W. Palliat Support Care. 2018 Jun;16(3):244-245. doi: 10.1017/S1478951518000408. Palliat Support Care. 2018. PMID: 29877784 Free PMC article. No abstract available.
Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial.
Chochinov HM, Kristjanson LJ, Breitbart W, McClement S, Hack TF, Hassard T, Harlos M. Chochinov HM, et al. Among authors: breitbart w. Lancet Oncol. 2011 Aug;12(8):753-62. doi: 10.1016/S1470-2045(11)70153-X. Epub 2011 Jul 6. Lancet Oncol. 2011. PMID: 21741309 Free PMC article. Clinical Trial.
INTERPRETATION: Although the ability of dignity therapy to mitigate outright distress, such as depression, desire for death or suicidality, has yet to be proven, its benefits in terms of self-reported end-of-life experiences support its clinical application for patients nearing d …
INTERPRETATION: Although the ability of dignity therapy to mitigate outright distress, such as depression, desire for death or suicidality, …
Psycho-oncology.
Breitbart WS, Alici Y. Breitbart WS, et al. Harv Rev Psychiatry. 2009;17(6):361-76. doi: 10.3109/10673220903465700. Harv Rev Psychiatry. 2009. PMID: 19968451 Review.
The psychosocial and psychiatric sequelae of cancer are highly prevalent, diverse, and challenging for clinicians to manage. ...This review presents an overview of the history of psycho-oncology, common psychological responses to cancer, factors in adapting to ca
The psychosocial and psychiatric sequelae of cancer are highly prevalent, diverse, and challenging for clinicians to manage. ...This …
Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
Hui D, Frisbee-Hume S, Wilson A, Dibaj SS, Nguyen T, De La Cruz M, Walker P, Zhukovsky DS, Delgado-Guay M, Vidal M, Epner D, Reddy A, Tanco K, Williams J, Hall S, Liu D, Hess K, Amin S, Breitbart W, Bruera E. Hui D, et al. Among authors: breitbart w. JAMA. 2017 Sep 19;318(11):1047-1056. doi: 10.1001/jama.2017.11468. JAMA. 2017. PMID: 28975307 Free PMC article. Clinical Trial.
OBJECTIVE: To compare the effect of lorazepam vs placebo as an adjuvant to haloperidol for persistent agitation in patients with delirium in the setting of advanced cancer. DESIGN, SETTING, AND PARTICIPANTS: Single-center, double-blind, parallel-group, randomized clinical …
OBJECTIVE: To compare the effect of lorazepam vs placebo as an adjuvant to haloperidol for persistent agitation in patients with delirium in …
258 results